Udin, Fatima .
HRN: 23-07-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
CEFUROXIME 750MG (VIAL)
03/24/2025
03/31/2025
IV
300mg
Q8h
PCAP C; AGE With Mod DHN
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes